Cardiología
Servicio
KU Leuven
Lovaina, BélgicaPublicaciones en colaboración con investigadores/as de KU Leuven (38)
2024
-
European Society for Organ Transplantation (ESOT) Consensus Statement on the Use of Non-invasive Biomarkers for Cardiothoracic Transplant Rejection Surveillance
Transplant International , Vol. 37
-
Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial
Circulation: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 457-473
-
International Society for Heart and Lung Transplantation Guidelines for the Evaluation and Care of Cardiac Transplant Candidates—2024
Journal of Heart and Lung Transplantation, Vol. 43, Núm. 10, pp. 1529-1628.e54
-
Risks and benefits of sharing patient information on social media: a digital dilemma
European Heart Journal - Digital Health, Vol. 5, Núm. 3, pp. 199-207
2023
-
Donor heart selection: Evidence-based guidelines for providers
Journal of Heart and Lung Transplantation, Vol. 42, Núm. 1, pp. 7-29
-
How does age affect outcomes after left ventricular assist device implantation: results from the PCHF-VAD registry
ESC Heart Failure, Vol. 10, Núm. 2, pp. 884-894
-
Sex-related differences in left ventricular assist device utilization and outcomes: results from the PCHF-VAD registry
ESC Heart Failure, Vol. 10, Núm. 2, pp. 1054-1065
2022
-
Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved
Nature Medicine, Vol. 28, Núm. 12, pp. 2512-2520
-
Impact of progressive aortic regurgitation on outcomes after left ventricular assist device implantation
Heart and Vessels, Vol. 37, Núm. 12, pp. 1985-1994
-
Improved survival of left ventricular assist device carriers in Europe according to implantation eras: results from the PCHF-VAD registry
European Journal of Heart Failure, Vol. 24, Núm. 7, pp. 1305-1315
-
Is degree of chronic illness management in heart transplant centers associated with better patient survival? Findings from the intercontinental BRIGHT study
Chronic Illness, Vol. 18, Núm. 4, pp. 806-817
-
Leadless pacemaker implant, anticoagulation status, and outcomes: Results from the Micra Transcatheter Pacing System Post-Approval Registry
Heart Rhythm, Vol. 19, Núm. 2, pp. 228-234
-
Transapical mitral valve implantation for treatment of symptomatic mitral valve disease: a real-world multicentre experience
European Journal of Heart Failure, Vol. 24, Núm. 5, pp. 899-907
2021
-
Clinical Risk Prediction in Patients With Left Ventricular Myocardial Noncompaction
Journal of the American College of Cardiology, Vol. 78, Núm. 7, pp. 643-662
-
Empagliflozin in heart failure with a preserved ejection fraction
New England Journal of Medicine, Vol. 385, Núm. 16, pp. 1451-1461
-
Heart failure in COVID-19: the multicentre, multinational PCHF-COVICAV registry
ESC Heart Failure, Vol. 8, Núm. 6, pp. 4955-4967
-
Leadless pacemaker implant with concomitant atrioventricular node ablation: Experience with the Micra transcatheter pacemaker
Journal of Cardiovascular Electrophysiology, Vol. 32, Núm. 3, pp. 832-841
-
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol
Journal of the American College of Cardiology, Vol. 78, Núm. 5, pp. 421-433
2020
-
Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial
European Journal of Heart Failure, Vol. 22, Núm. 12, pp. 2383-2392
-
Validation of the patient assessment of chronic illness care (PACIC) short form scale in heart transplant recipients: The international cross-sectional bright study
BMC Health Services Research, Vol. 20, Núm. 1